{"id":"W2119078920","doi":"10.1146/annurev-med-062209-095159","title":"Novel Oral Factor Xa and Thrombin Inhibitors in the Management of Thromboembolism","year":2010,"lang":"en","type":"review","venue":"Annual Review of Medicine","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":196,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Hamilton General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Dabigatran; Rivaroxaban; Apixaban; Medicine; Edoxaban; Direct thrombin inhibitor; Discovery and development of direct thrombin inhibitors; Clinical trial; Warfarin; Intensive care medicine; Pharmacology; Atrial fibrillation; Anticoagulant; Thrombin; Internal medicine; Platelet","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001644283,0.0004154838,0.004034937,0.000257802,0.00002427977,0.000003313533,0.000286822,0.000201508,0.0001950152],"category_scores_gemma":[0.0002706727,0.0002068552,0.0004072894,0.0007124473,0.0003512075,0.0000853904,0.0001500628,0.0004571332,0.000008348691],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000236831,"about_ca_system_score_gemma":0.00006344472,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004145445,"about_ca_topic_score_gemma":0.000004203926,"domain_scores_codex":[0.9968792,0.0001437676,0.001659734,0.0003348353,0.0007635576,0.0002188609],"domain_scores_gemma":[0.9980047,0.000303247,0.0008862714,0.0006058193,0.0001208566,0.00007915129],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000005331131,0.00002233303,0.00004448968,0.2513461,0.0002261582,0.00001045678,0.0001883953,3.387124e-9,0.000002017744,0.002498942,0.002569245,0.7430865],"study_design_scores_gemma":[0.0008700355,0.0001703843,0.001239756,0.2295271,0.003006701,0.00003360753,0.0001983525,1.21356e-7,5.384172e-7,0.00002553525,0.7648051,0.0001226989],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00002739567,0.9901096,0.000007609533,0.002969246,0.0003877717,0.00299651,0.00003994747,0.00001155831,0.003450324],"genre_scores_gemma":[0.00005880468,0.9980952,0.0003034612,0.0005977432,0.0004973949,0.00001622894,0.0001216223,0.00003176776,0.0002777369],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.7622359,"threshold_uncertainty_score":0.8435309,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1029954693666599,"score_gpt":0.4251439842323391,"score_spread":0.3221485148656792,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}